Back to top

Envision Healthcare Continues to Expand Physician Services

Read MoreHide Full Article

Envision Healthcare Corp. (EVHC - Free Report) is rapidly transforming its business after its merger with AMSURG last December. The deal created one of the nation's largest physician-staffing companies.

Envision Healthcare is now focusing on expanding its core business of physician services (contributing nearly 81% to total revenues) and selling non-core assets. In this vein, it recently announced that it will divest American Medical Response, its medical transportation business, to KKR & Co. in an all-cash deal valued at $2.4 billion.

The company is optimistic about the physician services market which is witnessing consolidation. Various factors such as mandate for clinical integration, value-based pricing innovation, lack of scaled physician practices, shortage of supply of physicians, hospital-cost pressures, MACRA readiness and increasing regulations will lead to increased demand for physician services.

In the first half of 2017, the physician services segment reported revenues of $3.19 billion, up from $0.86 billion in the year-ago quarter. Management expects same-contract revenue growth of 3% to 4% in the segment for 2017.

In order to expedite growth of the physician services market, the company is planning to grow inorganically. It had an active start to its acquisition strategy for 2017, and completed the buyout of nine physician practices in the six months ended Jun 30, 2017 for an aggregate $440.8 million.  

Recently, the company announced organizational changes to align its senior leadership structure with physician-centric strategy.

The company, however, saddles high debt and plans to utilize part of funds from the pending divestiture to reduce debt.

Other players from the same space are Amedisys Inc. (AMED - Free Report) , Chemed Corp. (CHE - Free Report) and LHC Group (LHCG - Free Report) .

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Amedisys Inc (AMED) - free report >>

LHC Group (LHCG) - free report >>

Chemed Corp. (CHE) - free report >>

Envision Healthcare Corporation (EVHC) - free report >>


More from Zacks Analyst Blog

You May Like